Artboard 33atençãoArtboard 18atualizarconectividadeArtboard 42boletocarrinhocartãoArtboard 45cartão SaraivacelularArtboard 42Artboard 23checkArtboard 28Artboard 17?compararcompartilharcompartilhar ativoArtboard 28Artboard 43Artboard 49Artboard 47Artboard 15Artboard 32ebookArtboard 22Artboard 5Artboard 25Artboard 1Artboard 42Artboard 11fecharfilmesArtboard 23gamesArtboard 4Artboard 9Artboard 6hqimportadosinformáticaArtboard 7Artboard 3Artboard 12Artboard 25Artboard 34Artboard 43Artboard 44curtirArtboard 24Artboard 13livrosArtboard 24Artboard 31menumúsicaArtboard 27Artboard 30Artboard 36Artboard 44outrospapelariaArtboard 17Artboard 6Artboard 27Artboard 30Artboard 29Artboard 26Artboard 2Artboard 20Artboard 35estrelaestrela ativorelógiobuscaArtboard 50Artboard 26toda saraivaArtboard 40Artboard 21Artboard 10Artboard 37usuárioArtboard 46Artboard 33Artboard 8seta
e-book

Poorly Soluble Drugs - Dissolution and Drug Release (Cód: 9452130)

Robert G. Bell; J. Derek Jackson; Gregory K. Webster

Taylor & Francis Ltd (Livros Digitais)

Ooops! Este produto não está mais a venda.
Mas não se preocupe, temos uma versão atualizada para você.

Ooopss! Este produto está fora de linha, mas temos outras opções para você.
Veja nossas sugestões abaixo!

R$ 749,85

em até 10x de R$ 74,99 sem juros

Total:

Em até 1x sem juros de


Crédito:
Boleto:
Cartão Saraiva:

Total:

Em até 10x sem juros de


Poorly Soluble Drugs - Dissolution and Drug Release

R$749,85

Descrição

This book is the first text to provide a comprehensive assessment of the application of fundamental principles of dissolution and drug release testing to poorly soluble compounds and formulations. Such drug products are, vis-à-vis their physical and chemical properties, inherently incompatible with aqueous dissolution. However, dissolution methods are required for product development and selection, as well as for the fulfillment of regulatory obligations with respect to biopharmaceutical assessment and product quality understanding. The percentage of poorly soluble drugs, defined in classes 2 and 4 of the Biopharmaceutics Classification System (BCS), has significantly increased in the modern pharmaceutical development pipeline. This book provides a thorough exposition of general method development strategies for such drugs, including instrumentation and media selection, the use of compendial and non-compendial techniques in product development, and phase-appropriate approaches to dissolution development.

Emerging topics in the field of dissolution are also discussed, including biorelevant and biphasic dissolution, the use on enzymes in dissolution testing, dissolution of suspensions, and drug release of non-oral products. Of particular interest to the industrial pharmaceutical professional, a brief overview of the formulation and solubilization techniques employed in the development of BCS class 2 and 4 drugs to overcome solubility challenges is provided and is complemented by a collection of chapters that survey the approaches and considerations in developing dissolution methodologies for enabling drug delivery technologies, including nanosuspensions, lipid-based formulations, and stabilized amorphous drug formulations.

Características

Produto sob encomenda Não
Marca Taylor & Francis Ltd (Livros Digitais)
Cód. Barras 9789814745468
Acabamento e-book
Início da Venda 06/01/2017
Territorialidade Internacional
Formato Livro Digital Pdf
Gratuito Não
Tamanho do Arquivo 26001
Proteção Drm Sim
Idioma 337
Código do Formato Pdf
Número de Páginas 728 (aproximado)
Ano da Publicação 2017
Peso 0.00 Kg
AutorRobert G. Bell; J. Derek Jackson; Gregory K. Webster